Kalra, Sanjay <br/><br/>
Initiation with once-daily BIAsp 30 results in superior outcome compared to insulin glargine in Asians with type 2 diabetes inadequately controlled by oral anti-diabetic drugs.  [electronic resource] 

 -  Diabetes research and clinical practice  Jun 2010 
 - 282-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8227 
<br/><br/><label>Standard No.: </label>10.1016/j.diabres.2010.03.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Asian People<br/>Biphasic Insulins<br/>Blood Glucose--metabolism<br/>Diabetes Mellitus, Type 2--blood<br/>Dosage Forms<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Hypoglycemia--prevention & control<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--analogs & derivatives<br/>Insulin Aspart<br/>Insulin Glargine<br/>Insulin, Isophane<br/>Insulin, Long-Acting<br/>International Agencies<br/>Male<br/>Middle Aged<br/>Treatment Outcome<br/>Young Adult